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Abstract
Punctate palmoplantar keratoderma (PPKP1; Buschke-Fischer-Brauer) is a
rare autosomal dominant inherited skin disease characterized by multiple
hyperkeratotic papules involving the palms and soles. Mutations have been found
at 2 loci, on chromosomes 15q22–15q24 and 8q24.13–8q24.21. We recently
identified mutations in 3 families, in the AAGAB gene on 15q, which encodes the
alpha- and gamma-adaptin-binding protein p34. The current study examined 14
additional families, comprising a total of 26 affected individuals and identified 8
novel mutations in 9 families. In one family a mutation that was present only in
the affected individuals was found, and in 4 other families, previously reported
mutations were found (1, 2). These results confirm the role of AAGAB in PPKP1.
Our findings suggest that there is no correlation with age, but with mechanical
factors. No additional obvious genotype–phenotype correlation was observed,
even when comparing different types of mutations. Rather, id...
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Punctate palmoplantar keratoderma (PPKP1; Buschke-
Fischer-Brauer) is a rare autosomal dominant inherited 
skin disease characterized by multiple hyperkeratotic 
papules involving the palms and soles. Mutations have 
been found at 2 loci, on chromosomes 15q22–15q24 and 
8q24.13–8q24.21. We recently identified mutations in 3 
families, in the AAGAB gene on 15q, which encodes the 
alpha- and gamma-adaptin-binding protein p34. The 
current study examined 14 additional families, compri-
sing a total of 26 affected individuals and identified 8 
novel mutations in 9 families. In one family a mutation 
representing a known SNP that was present only in the 
affected individuals was found, and in 4 other families, 
previously reported mutations were found (1, 2). These 
results confirm the role of AAGAB in PPKP1. Our fin-
dings suggest that there is no correlation with age, but 
with mechanical factors. No additional obvious geno-
type–phenotype correlation was observed, even when 
comparing different types of mutations. Rather, identi-
cal genotypes presented a very broad interfamilial and 
intrafamilial variability of phenotypes. Key words: pun-
ctate palmoplantar keratoderma; PPKP1; AAGAB; phe-
notype-genotype correlation.
Accepted Nov 24, 2015; Epub ahead of print Nov 26, 2015
Acta Derm Venereol 2016; XX: XX–XX.
Kathrin Giehl, Center for Rare and Genetic Skin Diseases, 
Department of Dermatology, Ludwig-Maximilian-Uni-
versity Munich, Frauenlobstr. 9-11, DE-80337 Munich, 
Germany. E-mail: kathrin.giehl@med.uni-muenchen.de
Punctate palmoplantar keratoderma type I (PPKP1; OMIM 
#148600), also called keratosis punctata palmoplantaris 
Buschke-Fischer-Brauer, was first described in 1910 
by Buschke & Fischer (3) and Brauer (4). It is mostly 
an autosomal dominant inherited disease, but sporadic 
cases have also been described (5). It is characterized by 
multiple hyperkeratotic papules with central indentation 
irregularly distributed on the palms and soles, as opposed 
to the mostly diffuse hyperkeratinization observed in other 
palmoplantar keratodermas (6, 7). In mechanically irritated 
areas, confluent plaques can be found. The lesions usually 
develop in early adolescence, but can also occur later in 
life (5). The incidence of PPKP1 has not been extensively 
evaluated, but has been estimated at 1.17 per 100,000 in-
habitants in Croatia (8). There have been reports in which 
punctate palmoplantar keratoderma was associated with 
the development of both early- and late-onset malignan-
cies, including squamous cell carcinomas (9–11). Possible 
treatments include keratolytic ointments, mechanical 
reduction of the hyperkeratoses, and systemic retinoids.
Recently, the identification of pathogenic mutations 
in AAGAB, which encodes the alpha- and gamma-
adaptin-binding protein p34, was described for the 
first time by the authors of the current paper and others 
(1, 12), after previous reports had mapped the critical 
region to chromosomes 15 and 8 (13–18). 
The current study examined 14 additional families for 
mutations in AAGAB, and studied a possible genotype–
phenotype relationship and the phenotypic variability 
within and between the families.
MATERIALS AND METHODS
Patients
All family members gave informed consent prior to partici-
pation. The study was approved by the institutional review 
board of the Ludwig-Maximilian University of Munich, and 
adhered to the principles of the Declaration of Helsinki. Blood 
samples were taken from all 33 investigated individuals. To 
establish the phenotype, the palms and soles of all individuals 
participating in this study were clinically assessed (mild: < 10 
papules on hands and feet; moderate: < 50 papules on hands and 
feet; severe: ≥ 50 papules on hands and feet, elevated lesions, 
confluent hyperkeratosis). All patients were asked to report a 
subjective severity score of 0–10 describing the pain caused 
by the skin lesions.
Mutation analysis
PCR primers were used as described earlier (1). The coding region 
and the exon-intron junctions were sequenced by the Sanger method 
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using Big Dye Terminator cycle sequencing kit v3.1 (Applied Bio-
systems/Life Technologies, Grand Island, NY, USA) and analysed 
on an ABI 3730 Genetic Analyzer (Applied Biosystems). Sequences 
were analysed for mutations with the Staden Package 2.0 (open 
source sequence analysis tool; http://staden.sourceforge.net). Seg-
regation analysis was performed on all available family members 
to confirm co-segregation with the phenotype in all pedigrees.
Computational analysis
Splice site variants were analysed in silico with CRYP-SKIP 9 
(http://cryp-skip.img.cas.cz/) to predict the probability of exon 
skipping or cryptic splice site activation of the mutated allele. 
The other changes were studied using different programs to 
predict whether variants are deleterious. PolyPhen-2 (http://
genetics.bwh.harvard.edu/pph2/bgi.shtml) classifies an amino 
acid substitution as probably damaging, possibly damaging, 
benign, or of unknown significance. SIFT (http://sift.jcvi.
org/) predicts whether a change is tolerated or damaging. For 
mutations affecting the start codon, the ORF Finder (Open 
Reading Frame Finder; http://www.ncbi.nlm.nih.gov/projects/
gorf/) from the US National Center for Biotechnology Infor-
mation (NCBI) was used to check if there was an alternative 
open reading frame with sequence similarity to the AAGAB 
open reading frame. This tool identifies all open reading frames 
using the standard or alternative genetic codes.
RESULTS
Mutation analysis of AAGAB in 26 affected individuals 
with palmoplantar keratoderma from 14 families revealed 
12 different mutations, 8 of which are novel. These chan-
ges include 3 mutations affecting the translation initiation 
site, 1 missense mutation, 3 frameshift mutations, 2 splice 
site mutations, and 3 nonsense mutations (Table SI1). 
Segregation analysis was performed in all cases when 
related individuals joined the study, and co-segregation 
of the mutation with the disease was observed in all 
available families (Fig. S11).
Keratoses on the soles were more severe than those 
on the palms, especially at points of pressure. Phe-
notypic variability could be observed between, as 
well as within, families (Fig. 1). Of the 26 affected 
individuals, 17 were women and 9 were men. The 
mean onset of disease was 18.2 years. A detailed des-
cription of the phenotypes is given in Table SII1.
1http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-2304
Fig. 1. Clinical images of phenotypic 
variation within one family and influence 
of water exposure and mechanical 
irritation. Moderate disseminated plane 
papules on (a) palm and (b) soles of 
83-year-old index patient (65325, 
family 1) with punctate palmoplantar 
keratoderma (PPKP1). The patient’s 
palm (a) before and (c) after 5 min of 
water exposure shows an increased 
prominence of papules. (d) The nephew 
(72382) has a very mild phenotype, 
which was more obvious at (e) the tips 
of the fingers, probably as a result of 
mechanical irritation associated with 
playing guitar for many years.
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The following genotype variants are described in 
Appendix S11:
• Mutations affecting the start codon
• Missense mutation
• Frameshift mutations
• Nonsense mutations
• Splice site mutations
DISCUSSION
This study examined 14 families with PPKP1 and iden-
tified 8 previously unknown mutations in 9 families, 3 
known mutations in 4 families, and a mutation, repre-
senting a known SNP in one family. In addition, using 
molecular genetic analysis, the aim of this study was to 
establish a genotype–phenotype correlation and examine 
for inter- and intra-familiar phenotypic variability. 
To date, a total of 38 mutations have been reported 
by several authors in families with PPKP1 Buschke-
Fischer-Brauer (2, 12, 19–27), as summarized in Fig. 
2. The mutations occurred in a variety of different 
populations, including individuals of European, Asian, 
African, Jewish, Mexican and Canadian origin. Among 
these mutations, 17 were frameshift mutations, 10 non-
sense mutations, 6 mutations affecting the start codon, 4 
splice site alterations, and 1 missense mutation. Except 
for exon 3, where only frameshift mutations have been 
reported, the other mutation types occurred in almost 
every coding exon of AAGAB, with the exception of ex-
ons 9 and 10 (Fig. 2). This broad range of mutation types 
and distribution reflects the high variability of clinical 
phenotypes among families, but does not explain the 
intra-familiar differences. Although we compared the 
clinical phenotypes of all patients with different types 
of mutations, no correlation between the severity of 
the phenotype and the type or location of the mutation 
could be identified. 
This phenotypic variability within families leads to 
the assumption that one or more modifier genes interact 
with AAGAB or with the gamma-adaptin and alpha-
adaptin subunits involved in clathrin-coated vesicle 
trafficking, thus influencing the final phenotype. 
In our study more women were affected than men 
(17 women, 9 men) although PPKP1 is inherited in an 
autosomal dominant manner. One explanation could be 
that more women are concerned about their skin and 
therefore more often seek help from a doctor. 
The spectrum of the clinical phenotypes between fa-
milies, within families, and among affected individuals 
varied extensively. The phenotypes ranged from very 
mild forms that were recognized only after another 
Fig. 2. Schematic representation of AAGAB showing mutation sites associated with punctate palmoplantar keratoderma (PPKP1). 
(A) Mutations in PPKP1 cases identified so far. (B) Genomic structure of AAGAB. Ten exons are indicated as black bars. The non-
coding parts of exons 1 and 10 are indicated with a smaller bar (gene annotation from RefSeq NM_024666.3; chromosomal location 
15q22.33–15q23). (C) Rab-like GTPase domain (P-loop_NTPase) and adaptin-binding domain in the protein sequence NP_078942 
(length = 315 amino acids). (D) Newly identified mutations in AAGAB in 10 families with PPKP1. The different mutations types are 
indicated with coloured boxes (blue = frameshift, green = affecting start codon, red = nonsense, purple = splice site, yellow = missense).
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family member with a more severe phenotype was di-
agnosed, to very severe forms in which the entire sole 
was affected with such thick hyperkeratosis that the 
patient required surgery. 
We found that the same mutation could lead to dif-
ferent phenotypes (Fig. 1) even in the same family 
(families 1, 4, 6). An example of clinical variability 
is shown in family 1 in Fig. 1. In family 4, the index 
patient had a moderate phenotype, and according to 
the patient’s history, the parents were not affected. 
For segregation analysis, the genotype of the parents 
was also examined, which revealed that the father also 
had the same genotype. A thorough skin examination 
uncovered only one lesion, which would otherwise 
have been interpreted as a small wart, but was now 
interpreted as a minimal affected phenotype. In family 
6, the phenotype varied from severe to very mild and 
clinically almost absent. 
The missense mutation in family 6, which is a known 
SNP with a minor allele frequency of 0.001 (dbSNP; 
http://www.ncbi.nlm.nih.gov/SNP/), is more likely a 
causal mutation than a rare polymorphism. Due to the 
low incidence and the possible late onset of the disease, 
it is very likely that this mutation leads to PPKP1 and 
that this disease is more common than reported. The 
segregation analysis also supports this assumption, as 
all affected members exhibit this mutation. Although 
this mutation was excluded in unaffected relatives of 
family 6, it will be necessary to detect this mutation in 
other independent patients to define its pathogenicity.
Four of the 26 affected individuals (66351 [family 
3], 71005 [family 4], 76427 [family 6], 72608 [family 
9]), all of whom are from different families, would not 
have been recognized as PPKP1 without the typical 
index patients. Mild forms of PPKP1 might often be 
overlooked or under-reported, and therefore the preva-
lence of this disease may be underestimated. 
The phenotype showing increased prominence of 
papules upon exposure to water (Fig. 1) has so far been 
diagnosed as keratosis palmoplantaris maculosa seu 
papulosa, as in the case of our patient (65325, family 1) 
and in the literature (28), hereditary chronic translucent 
papules of the palms and soles (29) or papulotranslu-
cent acrokeratoderma (30, 31). In these cases genetic 
investigation of the AAGAB gene will be necessary to 
confirm that these are variants of PPKP1.
Also, no correlation was found between the severity 
of the clinical phenotype and the subjective severity 
score (Table SII1). For example, all 4 affected indi-
viduals of family 6 reported relatively high severity 
scores, although 2 of them had only a mild or moderate 
phenotype. This demonstrates impressively how even 
seemingly mild phenotypic expression of PPKP1 can 
have a profound impact on the patients’ quality of life.
In 4 of 26 patients, there was no family history of 
palmoplantar keratoderma. Because of the phenotypic 
variability, it is still possible that these sporadic cases 
have a familial background. In our cases, it was not 
possible to elucidate this, as the other family members 
could not be examined clinically or by molecular ge-
netics. 
These observations suggest that environmental fac-
tors, such as manual labour, hobbies, walking longer 
distances, as well as the frequency of mechanical treat-
ment, may influence the phenotypic differences within 
a family. 
The results of the analysis of 26 individuals from 
14 families reported in this study, and those of other 
analyses reported by others, indicate that no clear 
phenotype–genotype correlation exists in PPKP1. Our 
findings suggest that there are no correlations with 
age, but with mechanical factors, and that there is an 
underestimation of the disease frequency. Differential 
diagnosis includes calluses due to pressure points, viral 
warts and porokeratosis punctate palmaris et plantaris 
and keratoses of toxic or paraneoplastic origin. As 
some entities of palmoplantar keratoderma are not 
distinct, they might often be misdiagnosed before the 
molecular era. The penetrance of PPKP1 seems to be 
highly variable. Regardless of the genotype, phenotypes 
vary considerably in PPKP1 and can even mimic other 
clinical entities of palmoplantar keratoderma. 
PPKP1 Buschke-Fischer-Brauer is an example of how 
genetic characterization can lead to the regrouping of 
clinical entities and to the definition of new entities.
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Appendix S1
SUPPLEMENTARY RESULTS
Mutations affecting the start codon
Mutation analysis revealed a c.1A>G substitution in exon 
1 that altered the translation initiation site of AAGAB. SIFT 
predicts this variant as deleterious; PolyPhen-2 predicts this 
variant as probably damaging. Here, the initiating methionine 
is lost, probably leading to a protein isoform initiated from a 
start codon downstream of the mutated initiation codon. This 
mutation (SFig. 1a, b) was seen in a 51-year-old man (66651, 
family 10) and in an unrelated 44-year-old woman (68077, 
family 4), both of German origin and with a mild to moderate 
phenotype. In the affected individual 66651, the age of onset 
was 40 years, no pain was reported, and there was no known 
family history of palmoplantar keratoderma. It was not possible 
to examine other family members for the PPKP1 phenotype.
In individual 68077, the age of onset was during puberty, and 
the pain due to the skin lesions was subjectively rated as 5 out 
of 10. The father (71005) showed the same substitution, but 
had such a mild phenotype that it was only identified during 
this study. The sister and mother were clinically unaffected, as 
confirmed by sequencing analysis.
A c.2T>A substitution in exon 1 which also probably leads to 
a protein isoform with a different start codon was seen in family 
3 (66350, SFig. 1c, d). PolyPhen-2 classifies this variant as pro-
bably damaging, while SIFT predicts this variant as deleterious. 
The affected individual was a 39-year-old woman (66350) of 
German origin who presented with a mild form of typical PPKP1. 
She first recognized skin lesions on her hands and feet at age 
20 years, but was not experiencing any pain. Her 67-year-old 
mother (66351) showed similar, but even milder, clinical lesions, 
which remained unnoticed until her daughter pointed them out.
An additional 13-bp deletion, c.1-1_12del, which includes 
the start codon of AAGAB, was identified (SFig. 1e, f). Due to 
the loss of the translation initiation site, this mutation probably 
SFig. 1. DNA sequencing showing all new identified mutations in AAGAB. AAGAB exon 1, with the wild-type DNA sequence for codons 1 and 2 (a) and 
the mutant sequence  showing c.1A>G (b) comprising the identified mutation in PPKP 4 and 10. AAGAB exon 1, with the wild-type DNA sequence for 
codons 1 and 2 (c) and the mutant sequence from PPKP 3 (d), showing c.2T>A. AAGAB exon 1, with the wild-type DNA sequence for codons 1 and 2 
(e) and the mutant sequence from PPKP 2 (f), showing c.1-1_12del. This three mutations (b, d, f) are likely leading to a protein isoform initiated from a 
downstream start codon. AAGAB exon 4, with the wild-type DNA sequence for codons 138–140 (g) and the mutant sequence from PPKP 6 (h), shows a 
missense mutation, c.415G>A, that leads to an aminoacid change, p.Val139Ile. AAGAB exon 2, with the wild-type DNA sequence for codons 26–29 (i) and 
the mutant sequence from PPKP 1 (j), shows a single base pair deletion, c.77delT, resulting in a frame shift and a protein change, p.Ile26Thrfs*11. AAGAB 
exon 5, with the wild-type DNA sequence for codon 167–171 (k) and the mutant sequence from PPKP 12 (l), showing a 2 bp insertion, c.506_507insAA, 
resulting in a frameshift and protein change, p.Asn169Lysfs*7. AAGAB exon 1, with the wild-type DNA sequence for codons 1–7 (m) and the mutant 
sequence from PPKP 14 (n), showing the mutation c.17_73+17delCCT(68bp)GCC, which leads to a frame shift after the first five amino acids, influencing 
the splice site of exon 1. AAGAB exon 5, with the wild-type DNA sequence for codons 170–172 (o) and the mutant sequence from PPKP 11 (p), showing 
a nonsense mutation, c.512G>A, which results in a protein change, p.Trp171*. AAGAB exon 1, with the wild-type DNA sequence for codons 23 and 24 
(q) and the mutant sequence from PPKP 8 (r), which shows a splice site mutation, c.73+1G>T.
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also leads to a protein isoform. This mutation was seen in a 
65-year-old woman (66352, family 2) with a typical moderate 
palmoplantar keratoderma since she was approximately 30 
years old and reported a pain score of 1. She could not recall 
having observed palmoplantar keratoderma in her parents 
who had died early. Her 41-year-old daughter did not show 
any clinical signs of PPKP1, as confirmed by genetic analysis.
Using the ORF Finder at NCBI, 18 additional open reading 
frames were predicted, all of which are remarkably shorter than 
the ORF comprising AAGAB.
Missense mutation
One missense mutation in the AAGAB gene was identified, 
c.415G>A in exon 4 (SFig. 1g, h) which leads to the amino 
acid change p.Val139Ile. The mutation comprises a known 
single-nucleotide polymorphism (SNP), rs138601241, which 
has a minor allele frequency of A=0.001/2. PolyPhen-2 classifies 
c.415G>A as probably damaging, whereas SIFT predicts the 
known transcripts to be tolerated. The affected individual was 
a 40-year-old man (69352, family 6) who was diagnosed with a 
mild clinical phenotype at 10 years of age, but whose condition 
worsened over time, resulting in a high level of pain. His 2 sisters 
(71033, 71035), his mother (71034), and a deceased uncle were 
affected. The disease was also confirmed in his nephew (76427) 
by mutation analysis, and subsequent clinical examination re-
vealed minimal lesions on both feet. In a segregation analysis, 
the affected individuals showed the same missense mutation. 
The phenotype varied within the family from severe (brother, 
69352), moderate–severe (sister, 71033), mild (mother, 71034), 
and very mild (sister, 71035) to almost absent (nephew, 76427).
Frameshift mutations
In all 4 affected individuals in family 1 (65325, 65604, 66550, 
72382), the same 1 base pair deletion in exon 2 (c.77delT) 
(SFig. 1i, j) was identified. This frameshift mutation results in 
a premature stop codon (p.Ile26Thrfs*11). The index patient of 
this family was an 83-year-old woman (65325) who had a mo-
derate water-sensitive palmoplantar punctate keratoderma (Fig. 
1a–c) with no pain since puberty. For many years the patient 
had been clinically diagnosed with keratosis palmoplantaris 
maculosa sive papulosa until she was included in our study and 
the mutation analysis for AAGAB was performed. Her daughter 
(66550), grandmother and great-grandmother, and even her 
sister (65604), despite taking 10 mg acitretin/day perorally, had 
a similar phenotype for PPKP1. The phenotype of the nephew 
(72382) was very mild (Fig. 1d); he played guitar regularly, 
which lead to callosities at the fingertips of his left hand (Fig. 
1e) that were not found on his right hand.
A second frameshift mutation was detected in a family (family 
12) of Belgian origin. Patient 76331 showed a 2-bp insertion 
in exon 5 (c.506_507insAA) (Fig. SFig. 1k, l). This mutation 
also results in a premature stop codon (p.Asn169Lysfs*7). The 
index patient of this family was a 57-year-old woman (76331) 
with a severe phenotype since 50 years of age. She complained 
of marked pain caused by skin changes on her hands and feet 
and she had no information about her family history.
A further frameshift mutation occurred in family 14. 
Individual 78323 showed a 74-bp deletion in exon 1 
(c.17_73+17delCCTGTG (62 bases) GGCGCC) (SFig. 1m, 
n) extending into intron 1, resulting in a frameshift after the 
first 5 amino acids and influencing the splice site. The index 
patient was a 55-year-old woman (78323) of German origin 
with a moderate phenotype since puberty. She experienced 
pain (score 6) caused by skin changes on her hands and feet. 
Her mother was reported to have similar skin changes, but she 
did not participate in the study.
Nonsense mutations
A novel nonsense mutation, c.512G>A, was identified in exon 
5 in a Belgian family (73417, family 11) (SFig. 1o, p), resulting 
in a stop codon at amino acid position 171 (p.Trp171*). The 
80-year-old index patient with a moderate–severe phenotype 
experienced some pain (scale 5). She first noticed skin changes 
at age 44 years, which worsened as she got older. Her mother 
and siblings had similar skin lesions.
A second nonsense mutation, c.370 C>T in exon 4, which 
leads to p.Arg124*, was previously identified in a family of 
German origin (1). The index patient was a 35-year-old woman 
(65536, family 9) with a moderate palmoplantar keratoderma 
since the age of 15 years and a pain score of 6–7. There was no 
known family history of palmoplantar keratoderma, but close 
examination of the parents revealed a very mild phenotype in 
the mother (72608), which was also confirmed by mutation 
analysis. 
A third nonsense mutation, c.481C>T, which leads to 
p.Arg161*, originally detected in a family of Croatian origin 
(1), was detected in family 5 and family 13. In family 5, a 
41-year-old woman (69783) had a typical moderate phenotype 
beginning at 20 years of age. Her father (70445) had a mild 
to moderate phenotype with an onset at 15 years of age. The 
sister was also affected, but refused to participate in the study. 
The index patient (76330) of family 13 was of African origin 
and 30 years old. He first noticed the skin changes 3 years pre-
viously and still had a mild phenotype. He had no knowledge 
of a family history and examination of other family members 
was not possible.
Splice site mutations
A novel splice site mutation, c.73+1G>T at the 3’ end of exon 
1, was identified in another Belgian family (family 8; SFig. 
12q, r). CRYP-SKIP predicted a higher probability of exon 
skipping at this splice site than activation of cryptic splice sites.
The 54-year-old index patient (70562) of this family had a 
moderate phenotype since the age of 17 years and experienced 
a lot of pain (score 7–8). Her daughter (73578) had had a mild 
phenotype since she was 13 years old.
Another splice site mutation, c.451+1G>A at the 3’ end of 
exon 4, was detected in a 49-year-old individual (69354, family 
7). This splice site mutation was also recently reported by Eytan 
et al. 2014 (2), who suggested that exon skipping at this mutated 
intronic splice site was due to aberrant RNA splicing. The age of 
onset of the skin changes was 20 years, and the patient reported 
a high pain score (7–9 over several years). There was a family 
history of PPKP1 (brother, nephew, and deceased father), but 
as this part of the family lives in Russia, skin examinations and 
DNA analyses were not possible.
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Fig. S1. Pedigrees of the 14 families with punctate palmoplantar keratoderma (PPKP1). Unaffected family members are indicated by clear symbols and 
affected members by black symbols. Index patients are marked with an arrow. Asterisks denote individuals genotyped for variants in AAGAB. To maintain 
confidentiality, the genotypes of unaffected individuals are not shown. Diagonal bars through the symbols denote deceased individuals. Question marks 
in the symbols denote missing information about the phenotype.
Acta Derm Venereol 96
Supplementary material to article by K. A. Giehl et al. ”Eight Novel Mutations Confirm the Role of AAGAB in Punctate Palmoplantar 
Keratoderma Type 1 (Buschke-Fischer-Brauer) and Show Broad Phenotypic Variability”
Ta
bl
e 
S
I.
 A
A
G
A
B
 m
ut
at
io
ns
 id
en
ti
fie
d 
in
 th
e 
cu
rr
en
t s
tu
dy
N
uc
le
ot
id
e 
ch
an
ge
Pr
ot
ei
n 
ch
an
ge
C
om
pu
ta
tio
na
l a
na
ly
si
s
Ex
on
Pr
ot
ei
n 
po
si
tio
n
Fa
m
ily
 (p
at
ie
nt
)
R
ef
er
en
ce
s
A
ffe
ct
in
g 
st
ar
t 
co
do
n
c.
1A
>G
p.
0?
Pr
ob
ab
ly
 d
am
ag
in
g 
de
le
te
rio
us
1
N
-te
rm
in
al
PP
K
P 
10
 (6
66
51
), 
PP
K
P 
4 
(6
80
77
, 7
10
05
)
C
ur
re
nt
 st
ud
y
c.
2T
>
A
p.
0?
Pr
ob
ab
ly
 d
am
ag
in
g 
de
le
te
rio
us
1
N
-te
rm
in
al
PP
K
P 
3 
(6
63
50
, 6
63
51
)
C
ur
re
nt
 st
ud
y
c.
1-
1_
12
de
l
p.
0?
–1
/1
N
-te
rm
in
al
PP
K
P 
2 
(6
63
52
)
C
ur
re
nt
 st
ud
y
M
is
se
ns
e
c.
41
5G
>A
p.
Va
l1
39
Ile
Pr
ob
ab
ly
 d
am
ag
in
g 
to
le
ra
te
d
4
B
et
w
ee
n 
R
ab
-l
ik
e 
G
T
P
as
e 
an
d 
ad
ap
tin
-b
in
di
ng
 d
om
ai
n
PP
K
P 
6 
(6
93
52
, 7
10
33
, 7
10
34
, 7
10
35
, 
76
42
7)
rs
13
86
01
24
1 
M
A
F:
 A
=0
.0
01
/2
Fr
am
es
hi
ft
c.
77
de
lT
p.
Il
e2
6T
hr
fs
*1
1
2
N
-te
rm
in
al
PP
K
P 
1 
(6
53
25
, 6
56
04
, 6
65
50
, 7
23
82
)
C
ur
re
nt
 st
ud
y
c.
50
6_
50
7i
ns
A
A
p.
A
sn
16
9L
ys
fs
*7
5
A
da
pt
in
-b
in
di
ng
PP
K
P 
12
 (7
63
31
)
C
ur
re
nt
 st
ud
y
c.
17
_7
3+
17
de
lC
C
T
(6
8b
p)
G
C
C
p.
?
Ex
on
 sk
ip
pi
ng
1/
+
1
N
-te
rm
in
al
PP
K
P 
14
 (7
83
23
)
C
ur
re
nt
 st
ud
y
N
on
se
ns
e
c.
51
2G
>A
p.
T
rp
17
1*
5
A
da
pt
in
-b
in
di
ng
PP
K
P 
11
 (7
34
17
)
C
ur
re
nt
 st
ud
y
c.
37
0C
>
T
p.
A
rg
12
4*
4
R
ab
-l
ik
e 
G
T
P
as
e
PP
K
P 
9 
(6
55
36
, 7
26
08
)
G
ie
hl
 e
t a
l. 
20
12
 (1
)
c.
48
1C
>
T
p.
A
rg
16
1*
5
A
da
pt
in
-b
in
di
ng
PP
K
P 
5 
(6
97
83
, 7
04
45
)
PP
K
P 
13
 (7
63
30
)
G
ie
hl
 e
t a
l. 
20
12
 (1
)
Po
hl
er
 e
t a
l. 
20
12
 (1
2)
Sp
lic
e-
si
te
c.
73
+
1G
>
T
p.
?
Ex
on
 sk
ip
pi
ng
+
1
N
-te
rm
in
al
PP
K
P 
8 
(7
05
62
, 7
35
78
)
C
ur
re
nt
 st
ud
y
c.
45
1+
1G
>
A
p.
?
Ex
on
 sk
ip
pi
ng
+
4
B
et
w
ee
n 
R
ab
-l
ik
e 
G
T
P
as
e 
an
d 
ad
ap
tin
-b
in
di
ng
 d
om
ai
n
PP
K
P 
7 
(6
93
54
)
Ey
ta
n 
et
 a
l. 
20
14
PP
K
P:
 p
un
ct
at
e 
pa
lm
op
la
nt
ar
 k
er
at
od
er
m
a.
Acta Derm Venereol 96
Supplementary material to article by K. A. Giehl et al. ”Eight Novel Mutations Confirm the Role of AAGAB in Punctate Palmoplantar 
Keratoderma Type 1 (Buschke-Fischer-Brauer) and Show Broad Phenotypic Variability”
Table SII. Clinical information about patients with AAGAB mutations
Patient
Sex/age, 
years
Severity of clinical 
phenotype (hands/feet)
Pain score 
1–10  Age of onset Family history Ancestry
Affecting start codon PPKP 10: 66651 M/51 Mild–moderate 0 40 Not known German
PPKP 4: 68077 F/44 Moderate 5 16 Yes German
PPKP 4: 71005 M/71 Very mild 0 Not recognized Yes German
PPKP 3: 66350 F/39 Mild–moderate 0 20 Yes German
PPKP 3: 66351 F/67 Very mild 0 Not recognized Yes German
PPKP 2: 66352 F/65 Moderate 1 30 Not known Romanian
Missense PPKP 6: 69352 M/40 Severe 8–9 10 Yes German
PPKP 6: 71033 F/34 Moderate–severe 7–9 6 Yes German
PPKP 6: 71034 F/70 Moderate 6–7 6 Yes German
PPKP 6: 71035 F/45 Mild 8 40 Yes German
PPKP 6: 76427 M/18 No skin changes 0 Not recognized Yes German
Frameshift PPKP 1: 65325 F/83 Moderate, water sensitive 0 16 Yes German
PPKP 1: 65604 F/74 Moderate, water sensitive 0–5 30 Yes German
PPKP 1: 66550 F/55 Moderate, water sensitive 0 16 Yes German
PPKP 1: 72382 M/35 Mild 0–2 16 Yes German
PPKP 12: 76331 M/57 Severe 9 50 Not known Belgian
PPKP 14: 78323 F/55 Moderate 6 15 Yes German
Nonsense PPKP 11: 73417 F/80 Moderate–severe 5 44 Yes Belgian
PPKP 9: 65536 F/35 Moderate 6–7 15 Yes German
PPKP 9: 72608 F/53 Very mild 0 Not recognized Yes German
PPKP 5: 69783 F/41 Moderate 0 20 Yes German
PPKP 5: 70445 M/75 Mild–moderate 0 15 Yes German
PPKP 13: 76330 M/30 Mild 6 27 Not known African
Splice-site
 
PPKP 8: 70562 F/54 Moderate 7–8 17 Yes Belgian
PPKP 8: 73578 F/27 Mild Not known 13 Yes Belgian
PPKP 7: 69354 M/49 Moderate 7–9 20 Yes Russian
PPKP: punctate palmoplantar keratoderma.
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